Therapeutic approach to triple negative breast cancer in pregnant woman: case report
DOI:
https://doi.org/10.29289/2594539420240035Palavras-chave:
therapeutic approach, triple negative breast cancer, pregnantResumo
Pregnancy-associated breast cancer includes tumors that occur during pregnancy, lactation, or within one year postpartum. It is a rare clinical condition, with an incidence ranging from 1:3,000 to 1:10,000 pregnancies. Therapeutic strategies take into account factors such as tumor staging, patient characteristics, and gestational age. Radical mastectomy was the main surgical intervention in triple-negative breast cancer. Currently, studies suggest that mastectomy should not be mandatory for the treatment of breast cancer solely due to the presence of pregnancy, and breast conservation is discussed whenever possible. Despite the aggressive biology of the triple-negative subtype, approximately 40% of patients have tumors that are highly sensitive to chemotherapy, achieving a complete pathological response. The objective of this study was to report a clinical case of breast cancer in a young pregnant patient, describing the clinical presentation, histological characteristics, as well as the diagnostic methods and therapeutic measures adopted, with the aim of contributing didactically to the academic community, offering theoretical support for the improvement of clinical practice in the management of triple-negative breast cancer during and after the gestational period.
Downloads
Referências
1. Brasil. Instituto Nacional de Câncer. Controle do Câncer de Mama: Conceito e Magnitude [Internet]. Rio de Janeiro; 2022 [cited on 2024 May 13]. Available from: https://www.gov.br/inca/pt-br/assuntos/gestor-e-profissional-de-saude/controle-do-cancer-de-mama/conceito-e-magnitude.
2. Boere I, Lok C, Poortmans P, Koppert L, Painter R, Heudvel-Eibrink M, et al. Breast cancer during pregnancy: epidemiology, phenotypes, presentation during pregnancy and therapeutic modalities. Best Pract Res Clin Obstet Gynaecol. 2022;82:46-59. https://doi.org/10.1016/j.bpobgyn.2022.05.001
3. Carvalho CM, Cândido EB, Furtado RS, Almeida JVQ, Silva Filho AL. Aspectos clínicos do câncer durante o período gestacional: desafios diagnósticos e terapêuticos. Femina. 2022;50(10):582-88.
4. Liberale V, Tripodo E, Ottino L, Biglia N. Surgery on breast cancer in pregnancy. Transl Cancer Res. 2019;8:s493-s502. https://doi.org/10.21037/tcr.2019.07.16
5. Ruiz R, Herrero C, Strasser-Weippl K, Touya D, Louis J, Bukowski A, et al. Epidemiology and pathophysiology of pregnancy-associated breast cancer: A review. The Breast. 2017;35:136-41. https://doi.org/10.1016/j.breast.2017.07.008
6. Thorne C, Lee AV. Cross Talk Between Estrogen Receptor and IGF Signaling in Normal Mammary Gland Development and Breast Cancer. Breast Dis. 2003;17:105-14. https://doi.org/10.3233/bd-2003-17110
7. Aerts L, Christianes MR, Enzlin P, Neven P, Amant F. Sexual functioning in women after mastectomy versus breast conserving therapy for early-stage breast cancer: a prospective controlled study. The Breast. 2014;23(5):629-36. https://doi.org/10.1016/j.breast.2014.06.012
8. Baranova A, Krasnoselskyi M, Starikov V, Kartashov S, Zhulkevych I, Vlasenko V, et al. Triple-negative breast cancer: current treatment strategies and factors of negative prognosis. J Med Life . 2022;15(2):153-61. https://doi.org/10.25122/jml-2021-0108
9. Symmans WF, Wei C, Gould R, Yu X, Zhang Y, Liu M, et al. Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype. J Clin Oncol. 2017;35(10):1049-60. https://doi.org/10.1200/JCO.2015.63.1010
10. Loibl S, Azim Jr. HA, Bachelot T, Berveiller P, Bosch A, Cardonick E, et al. ESMO Expert Consensus Statements on the management of breast cancer during pregnancy (PrBC). Ann Oncol. 2023;34(10):849-66. https://doi.org/10.1016/j.annonc.2023.08.001
11. National Comprehensive Cancer Network. Breast Cancer: Clinical Practice Guidelines in Oncology [Internet]. National Comprehensive Cancer Network; 2024 [cited on 2024 Jul 27]. Available from: https://jnccn.org/view/journals/jnccn/22/5/article-p331.xml.
12. Monteiro DLM, Trajano AJB, Menezes DCS, Silveira NLM, Magalhães AC, Miranda FRD, et al. Câncer de mama na gravidez e quimioterapia: revisão sistemática. AMB Rev Assoc Med Bras. 2013;59(2):174-80. https://doi.org/10.1016/j.ramb.2012.10.003
13. Mayer IA, Zhao F, Arteaga CL, Symmans WF, Park BH, Burnette BL, et al. Randomized Phase III Postoperative Trial of Platinum-Based Chemotherapy Versus Capecitabine in Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy: ECOG-ACRIN EA1131. J Clin Oncol. 2021;39(23):2539-51. https://doi.org/10.1200/JCO.21.00976
14. Geyer CE, Sikov WM, Huober J, Rugo HS, Wolmark N, O’Shaughnessy J, et al. Long-term efficacy and safety of addition of carboplatin with or without veliparib to standard neoadjuvant chemotherapy in triple-negative breast cancer: 4-year followup data from BrighTNess, a randomized phase III trial. Ann Oncol. 2022;33(4):384-94. https://doi.org/10.1016/j.annonc.2022.01.009
15. Wolters V, Heimovaara J, Maggen C, Cardonick E, Boeré I, Lenaerts L, et al. Management of pregnancy in women with cancer. Int J Gynecol Can. 2021;31(3):314-22. https://doi.org/10.1136/ijgc-2020-001776
16. Toesca A, Gentilini O, Peccatori F, Azim Jr HA, Amant F. Locoregional treatment of breast cancer during pregnancy. Gynecol Surg. 2014;11(4):279-84. https://doi.org/10.1007/s10397-014-0860-6
17. Rojas KE, Bilbro N, Manasseh DM, Borgen PI. A Review of Pregnancy-Associated Breast Cancer: Diagnosis, Local and Systemic Treatment, and Prognosis. J Womens Health. 2019;28(6):778-84. https://doi.org/10.1089/jwh.2018.7264
18. Matthes AGZ, Vieira RAC, Melo FY, Mendonça MLH, Bailão Jr A, Haikel RL, et al. Biópsia do linfonodo sentinela para o câncer de mama com anestesia local. Rev Bras Mastologia. 2011;20(4):170-6.
19. Omranipour R. Cirurgia de câncer de mama associado à gravidez. Springer. 2020:95-9. https://doi.org/10.1007/978-3-030-41596-9_12
20. Voulgaris E, Pentheroudakis G, Pavlidis N. Cancer and pregnancy: a comprehensive review. Surg Oncol. 2011;20(4):e175-85. https://doi.org/10.1016/j.suronc.2011.06.002
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 2025 Thalita Pereira da Silva, Vitória Rocha de Lima, Ana Thereza Uchoa
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
